Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.42
-0.67 (-6.04%)
At close: Sep 23, 2026, 4:00 PM EDT
10.24
-0.18 (-1.77%)
After-hours: Sep 23, 2026, 7:55 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $647.69 million as of September 23, 2026. Its market cap has increased by 192.45% in one year.
Market Cap
647.69M
Enterprise Value
392.07M
1-Year Change
192.45%
Ranking
Category
Stock Price
$10.42
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $647.69M, an increase of 82.55%. That is a compound annual growth rate of 20.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 647.69M | 236.42% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 723.58M |
| Nuvectis Pharma | 716.14M |
| MiMedx Group | 701.11M |
| Crescent Biopharma | 695.52M |
| Zevra Therapeutics | 693.01M |
| OmniAb | 665.89M |
| Aura Biosciences | 659.56M |
| Neurogene | 651.77M |